机构名称：
¥ 3.0
RosetteArray ® Platform for Quantitative High-Throughput Screening of Human Neurodevelopmental Risk Brady F. Lundin 1,2,3,* , Gavin T. Knight 3,4,* , Nikolai J. Fedorchak 4 , Kevin Krucki 4 , Nisha Iyer 1,3 , Jack E. Maher 3 , Nicholas R. Izban 3 , Abilene Roberts 3 , Madeline R. Cicero 3，Joshua F. Robinson 5，Bermans J. Iskandar 6，Rebecca Willett 4,7和Randolph S. Ashton和Randolph S. Ashton 1,3,4,8 1生物医学工程系，威斯康星州麦迪逊，麦迪逊大学，威斯康星州麦迪逊大学，美国威斯康星州53705，美国23705，美国2 Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, WI 53715, USA 4 Neurosetta LLC, 330 N. Orchard Street Rm 4140A, Madison, WI 53715 USA 5 Center of Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94143, USA 6 Department of Neurological Surgery, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI 53705, USA 7 Departments of Statistics and Computer Science, University of Chicago, Chicago, IL 60637, USA 8 Lead Contact, correspondence: rashton2@wisc.edu *Equal contribution SUMMARY Neural organoids have revolutionized how human neurodevelopmental disorders (NDDs) are研究。然而，它们用于筛选复杂的NDD病因和药物发现的效用受到缺乏可扩展和可量化的推导格式的限制。在这里，我们描述了Rosettearray®
rosettearray平台用于定量高通量...
主要关键词
相关文件推荐
